Membrane microdomains and caveolae

Current Opinion in Cell Biology

Volumn 11, Issue 4, 1999, Pages 424-431

  Kurzchalia, Teymuras V ^a,b   Parton, Robert G ^c  

^a MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; CHOLESTEROL; GLYCOSPHINGOLIPID; MEMBRANE PROTEIN;

APICAL MEMBRANE; CELL MEMBRANE; EPITHELIUM CELL; EUKARYOTIC CELL; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033179849     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)80061-1     Document Type: Article

References (89)

1. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 1997, 387:569-572.
2. Harder T, Simons K: Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr Opin Cell Biol 1997, 9:534-542.
3. Kurzchalia T, Hartmann E, Dupree P: Guilt by insolubility: Does a protein's detergent insolubility reflect caveolar location. Trends Cell Biol 1995, 5:187-189.
4. Parton RG: Caveolae and caveolins. Curr Opin Cell Biol 1996, 8:542-548.
5. Brown D, Rose J: Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992, 68:533-544.
6. Mayor S, Rothberg KG, Maxfield FR: Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking. Science 1994, 264:1948-1951.
7. Mayor S, Maxfield FR: Insolubility and redistribution of GPI-anchored proteins at the cell surface after detergent treatment. Mol Biol Cell 1995, 6:929-944.
8. Wu M, Fan J, Gunning W, Ratnam M: Clustering of GPI-anchored folate receptor independent of both cross-linking and association with caveolin. J Membr Biol 1997, 159:137-147.
9. Sheets ED, Lee GM, Simson R, Jacobson K: Transient confinement of a glycosylphosphatidylinositol-anchored protein in the plasma membrane. Biochemistry 1997, 36:12449-12458.
10. Varma R, Mayor S: GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 1998, 394:798-801. Using a novel FRET-approach, this study represents the first demonstration of the existence of submicron size clusters of GPI-APs on the surface of living cells. The clustering of GPI-AP seems to depend on the cholesterol content of the membrane. The described FRET-approach potentially could be used to detect other interacting molecules in intact cells. (See also De Angelis et al. [11•].)
11. De Angelis DA, Miesenbock G, Zemelman BV, Rothman JE: PRIM: Proximity imaging of green fluorescent protein-tagged polypeptides. Proc Natl Acad Sci USA 1998, 95:12312-12316. The authors discovered a novel property of GFP to change its relative intensity ratio at maxima of emission upon dimerization. Authors show that GFP molecules with a GPI-tail are loosely associated or that this association is rather transient. Like the above-mentioned FRET-approach, the method could be applied to detect interacting molecules in the living cell.
12. Kenworthy AK, Edidin M: Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of <100 Å using imaging fluorescence resonance energy transfer. J Cell Biol 1998, 142:69-84.
13. Friedrichson T, Kurzchalia TV: Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature 1998, 394:802-805. This study provides compelling biochemical data for the association of GPI-APs on the surface of living cells. A reporter GPI-AP, GH-DAF, was found in clusters of about 15 molecules when a conventional cross-linking approach was applied. The clustering was specific for the GPI-anchored form of the molecule and was dependent on cholesterol. Remarkably, the clusters became much larger upon detergent extraction of cells. This finding makes a link between small intact rafts and TX-insoluble aggregates for the first time.
14. Harder T, Scheiffele P, Verkade P, Simons K: Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 1998, 141:929-942. Coalescence of small rafts into larger patches upon antibody cross-linking is described. Whereas patches of raft molecules (GPI-APs, GM1 or influenza hemagglutinin) were overlapping, non-raft molecules (transferrin receptor) were found in separate patches. This segregation was abrogated when cells were depleted of cholesterol. The patches of raft proteins accumulated the Src-kinase Fyn on the cytoplasmic leaflet of the membrane.
15. Harder T, Simons K: Clusters of glycolipid and glycosylphosphatidylinositol-anchored proteins in lymphoid cells: Accumulation of actin regulated by local tyrosine phosphorylation. Eur J Immunol 1999, 29:556-562.
16. Wülfing C, Davis MM: A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 1998, 282:2266-2269. See annotation [17••].
17. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A: T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 1999, 283:680-682. These two papers visualize the formation of immunological synapses between T and antigen-presenting cells. Costimulation of T cell receptor by CD28 leads to active transport of lipids (GM1) and GPI-APs (CD59) to the site of cell-to-cell contact. A novel mechanism to explain the T cell activation, based on the formation of large rafts, is suggested.
18. Montixi C, Langlet C, Bernard AM, Thimonier J, Dubois C, Wurbel MA, Chauvin JP, Pierres M, He HT: Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J 1998, 17:5334-5348. See annotation [19•].
19. Xavier R, Brennan T, Li Q, McCormack C, Seed B: Membrane compartmentation is required for efficient T cell activation. Immunity 1998, 8:723-732. This study demonstrates that T cell activation leads to compartmentalization of signaling molecules into rafts as revealed by Triton-X-insolubility. Dispersion of rafts by filipin and nystatin, or cholesterol-depletion, abolishes T cell activation and compartmentalization of signaling molecules.
20. Melkonian KA, Ostermeyer AG, Chen JZ, Roth MG, Brown DA: Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J Biol Chem 1999, 274:3910-3917.
21. Scheiffele P, Verkade P, Fra AM, Virta H, Simons K, Ikonen E: Caveolin-1 and -2 in the exocytic pathway of MDCK cells. J Cell Biol 1998, 140:795-806. Caveolin-1/-2 hetero-oligomers are present in basolaterally-destined vesicles in MDCK cells, whereas caveolin-1 homo-oligomeric complexes are targeted to the apical surface. Caveolin-1 antibodies specifically inhibit apical transport of a viral protein, without affecting basolateral transport. These results implicate caveolin-1 in the machinery involved in apical exocytic transport and also suggest that mechanisms must exist to recycle caveolins back to the Golgi complex.
22. Parton RG, Way M, Zorzi N, Stang E: Caveolin-3 associates with developing T-tubules during muscle differentiation. J Cell Biol 1997, 136:137-154.
23. Fra AM, Williamson E, Simons K, Parton RG: De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 1995, 92:8655-8659.
24. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, Simons K: VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 1995, 92:10339-10343.
25. Fra AM, Masserini M, Palestini P, Sonnino S, Simons K: A photoreactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett 1995, 375:11-14.
26. Parton RG, Simons K: Digging into caveolae. Science 1995, 269:1398-1399.
27. Henley JR, Krueger EW, Oswald BJ, McNiven MA: Dynamin mediated internalization of caveolae. J Cell Biol 1998, 141:85-99. See annotation [28•].
28. Oh P, McIntosh DP, Schnitzer JE: Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol 1998, 141:101-114. These two studies suggest that dynamin function is not restricted to clathrin coated pits but is also required for caveolae budding. In contrast to coated pits, dynamin sits at the neck of caveolae prior to budding, at least in endothelial cells. In both studies [27•,28•] inhibition of dynamin function inhibited cholera toxin endocytosis - a marker internalized at least partially through caveolae.
29. Parton RG, Joggerst B, Simons K: Regulated internalization of caveolae. J Cell Biol 1994, 127:1199-1215.
30. Anderson RG: Plasmalemmal caveolae and GPI-anchored membrane proteins. Curr Opin Cell Biol 1993, 5:647-652.
31. Mayor S, Sabharanjak S, Maxfield FR: Cholesterol-dependent retention of GPI-anchored proteins in endosomes. EMBO J 1998, 17:4626-4638. This study addresses a long-standing question regarding the involvement of endosomes in GPI-anchored protein trafficking. In contrast to a previous model, it is shown that GPI-anchored folate receptors are internalized into transferrin-containing early endosomes; cholesterol plays a role in retention of the folate receptor in the recycling endosomes. These results suggest an important role for the GPI-anchor in intracellular sorting and suggest an endosomal mechanism - rather than caveolae-mediated potocytosis - in folate uptake.
32. Vieira AV, Lamaze C, Schmid SL: Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 1996, 274:2086-2089.
33. Ahn S, Maudsley S, Luttrell LM, Lefkowitz RJ, Daaka Y: Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling. J Biol Chem 1999, 274:1185-1188.
34. Pol A, Calvo M, Enrich C: Isolated endosomes from quiescent rat liver contain the signal transduction machinery. Differential distribution of activated Raf-1 and Mek in the endocytic compartment FEBS Lett 1998, 11:34-38.
35. Park H, Go YM, St John PL, Maland MC, Lisanti MP, Abrahamson DR, Jo H: Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. J Biol Chem 1998, 273:32304-32311. See annotation [37•].
36. Rizzo V, McIntosh DP, Oh P, Schnitzer JE: In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J Biol Chem 1998, 273:34724-34729. See annotation [37•].
37. Rizzo V, Sung A, Oh P, Schnitzer JE: Rapid mechanotransduction in situ at the luminal cell surface of vascular endothelium and its caveolae. J Biol Chem 1998, 273:26323-26329. These three studies by Park et al. [35•] and Rizzo et al. [36•,37•] suggest a role for caveolae as flow-sensing organelles, able to convert mechanical stimuli into an intracellular signal.
38. 2+ waves preferentially originate at specific loci in caveolin-rich cell edges. Proc Natl Acad Sci USA 1998, 95:5009-5014.
39. Orlandi PA, Fishman PH: Filipin-dependent inhibition of cholera toxin: Evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 1998, 141:905-915.
40. Wolf AA, Jobling MG, Wimer-Mackin S, Ferguson-Maltzman M, Madara JL, Holmes RK, Lencer WI: Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia. J Cell Biol 1998, 141:917-927.
41. Majoul I, Sohn K, Wieland FT, Pepperkok R, Pizza M, Hillemann J, Soling HD: KDEL receptor (Erd2p)-mediated retrograde transport of the cholera toxin A subunit from the Golgi involves COPI, p23, and the COOH terminus of Erd2p. J Cell Biol 1998, 143:601-612.
42. Kartenbeck J, Stukenbrok H, Helenius A: Endocytosis of simian virus 40 into the endoplasmic reticulum. J Cell Biol 1989, 109:2721-2729.
43. Anderson HA, Chen Y, Norkin LC: Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell 1996, 7:1825-1834.
44. Stang E, Kartenbeck J, Parton RG: Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Mol Biol Cell 1997, 8:47-57.
45. Baorto DM, Gao Z, Malaviya R, Dustin ML, van der Merwe A, Lublin DM, Abraham SN: Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 1997, 389:636-639.
46. Okamoto T, Schlegel A, Scherer PE, Lisanti MP: Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane. J Biol Chem 1998, 273:5419-5422. Comprehensive review of the signaling functions of caveolae and the role of the caveolae scaffolding domain as a distinct module, which acts as a negative regulator of signaling molecules.
47. Shaul PW, Anderson RG: Role of plasmalemmal caveolae in signal transduction. Am J Physiol 1998, 275:L843-L851. An up-to-date review of the caveolae system and its role in signaling.
48. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP: Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 1997, 272:6525-6533.
49. Feron O, Saldana F, Michel JB, Michel T: The endothelial nitric oxide synthase-caveolin regulatory cycle. J Biol Chem 1998, 273:3125-3128.
50. Feron O, Dessy C, Opel DJ, Arstall MA, Kelly RA, Michel T: Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J Biol Chem 1998, 273:30249-30254. Elegant studies suggesting a role for the CSD of caveolin-3 in modulating the function of eNOS in regulating myocyte contractility.
51. i2α in the plasma membrane: A critical evaluation by immunocytochemistry. FEBS Lett 1997, 415:139-144.
52. Huang C, Hepler JR, Chen LT, Gilman AG, Anderson RGW, Mumby SM: Organization of G proteins and adenylyl cyclase at the plasma membrane. Mol Biol Cell 1997, 8:2365-2378.
53. Wary KK, Mariotti A, Zurzolo C, Giancotti FG: A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 1998, 94:625-634. Normal (nontransformed) cells require substratum contact to proliferate. This study suggests a role in this process for a soluble pool of caveolin-1, acting as a membrane adaptor to link integrin subunits to Fyn and thus initiating a sequence of events, involving Shc and Grb2, which lead to cell division. A direct role for caveolin in this process is suggested by immunoprecipitation and by comparison of caveolin-1-expressing, and caveolin-1-deficient, cells. Surprisingly, all tested integrins associated with soluble caveolin-1 showing that integrin association with caveolin-1 is not sufficient for Shc recruitment.
54. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers MG Jr, Ishikawa Y: Caveolin is an activator of insulin receptor signaling. J Biol Chem 1998, 273:26962-26968.
55. Koleske AJ, Baltimore D, Lisanti MP: Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 1995, 92:1381-1385.
56. Engelman JA, Wykoff CC, Yasuhara S, Song KS, Okamoto T, Lisanti MP: Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 1997, 272:16374-16381.
57. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, Lisanti MP: Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 1998, 17:6633-6648. Direct evidence of a role for caveolin-1 in regulating cell division. NIH3T3 cell lines with reduced caveolin-1 expression show anchorage-independent cell growth and form tumors in immunodeficient mice. Caveolin-1 deficiency causes hyperactivation of the MAPK cascade. These results, together with evidence for regulated expression of caveolin-1 by cell density and growth factors, suggest a vital role for caveolin-1 in regulating cell division via the MAPK pathway.
58. Engelman JA, Lee RJ, Karnezis A, Bearss DJ, Webster M, Siegel P, Muller WJ, Windle JJ, Pestell RG, Lisanti MP: Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biol Chem 1998, 273:20448-20455.
59. Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, Nasu Y, Bangma CH, Kattan MW, Scardino PT, Thompson TC: Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res 1998, 4:1873-1880.
60. Fielding CJ, Fielding PE: Intracellular cholesterol transport. J Lipid Res 1997, 38:1503-1521.
61. Fielding CJ, Bist A, Fielding PE: Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA 1997, 94:3753-3758.
62. Hailstones D, Sleer LS, Parton RG, Stanley KK: Regulation of caveolin and caveolae by cholesterol in MDCK cells. J Lipid Res 1998, 39:369-379.
63. Smart EJ, Ying Y, Donzell WC, Andersen RG: A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J Biol Chem 1996, 271:29427-29435.
64. Uittenbogaard A, Ying Y, Smart EJ: Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking. J Biol Chem 1998, 273:6525-6532.
65. Babitt J, Trigatti B, Rigotti A, Smart EJ, Anderson RG, Xu S, Krieger M: Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 1997, 272:13242-13249.
66. Fielding CJ, Bist A, Fielding PE: Intracellular cholesterol transport in synchronized human skin fibroblasts. Biochemistry 1999, 38:2506-2513.
67. Dupree P, Parton RG, Raposo G, Kurzchalia TV, Simons K: Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J 1993, 12:1597-1605.
68. Smart EJ, Ying YS, Conrad PA, Anderson RG: Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J Cell Biol 1994, 127:1185-1197.
69. Cooper MK, Porter JA, Young KE, Beachy PA: Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 1998, 280:1603-1607.
70. Osborne TF, Rosenfeld JM: Related membrane domains in proteins of sterol sensing and cell signaling provide a glimpse of treasures still buried within the dynamic realm of intracellular metabolic regulation. Curr Opin Lipidol 1998, 9:137-140. A review of a fascinating area of cell biology, discussing a family of membrane proteins (Patched, NPC1, 3HMGCoA reductase, and Sterol regulatory element binding protein), which have apparently diverse functions but share conserved sterol-sensing domains.
71. Porter JA, Young KE, Beachy PA: Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996, 274:255-259.
72. Furuchi T, Anderson RG: Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem 1998, 273:21099-21104. This study shows for the first time that there is a direct link between caveolar domain cholesterol levels and the MARK pathway. Cholesterol depletion caused a reduction in components of the MAPK cascade associated with a caveolar fraction. Despite this reduction, epidermal growth factor EGF causes hyperactivation of the remaining Erk in the fraction. Remarkably, cholesterol depletion alone causes a reversible stimulation of MAPK suggesting that reduced cholesterol is sufficient to activate pathways leading to cell division. It is postulated that caveolin-1 might play a role as a cholesterol transporter involved in maintaining caveolae cholesterol and that inhibition of the MAPK pathway by caveolin expression in transformed cells might occur through an effect on cholesterol.
73. Scheel J, Srinivasan J, Honnert U, Henske A, Kurzchalia TV: Involvement of Caveolin-1 in meiotic cell cycle progression in C. elegans. Nat Cell Biol 1999, 1:127-129.
74. Roy S, Luetterforst R, Harding A, Apolloni A, Etheridge M, Stang E, Rolls B, Hancock JF, Parton RG: Dominant negative caveolin selectively inhibits H-Ras function by disrupting cholesterol-rich domains. Nat Cell Biol 1999, 1:98-105.
75. Hancock JF, Paterson H, Marshall CJ: A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21 ras to the plasma membrane. Cell 1990, 63:133-139.
76. Hiebl-Dirschmied CM, Entler B, Glotzmann C, Maurer Fogy I, Stratowa C, Prohaska R: Cloning and nucleotide sequence of cDNA encoding human erythrocyte band 7 integral membrane protein. Biochim Biophys Acta 1991, 1090:123-124.
77. Snyers L, Umlauf E, Prohaska R: Oligomeric nature of the integral membrane protein stomatin. J Biol Chem 1998, 273:17221-17226.
78. Huang M, Gu G, Ferguson EL, Chalfie M: A stomatin-like protein necessary for mechanosensation in C. elegans. Nature 1995, 378:292-295.
79. Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP. Lodish HF: Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem 1997, 272:13793-13802.
80. Lang DM, Lommel S, Jung M, Ankerhold R, Petrausch B, Laessing U, Wiechers MF, Plattner H, Stuermer CA: Identification of reggie-1 and reggie-2 as plasmamembrane-associated proteins which cocluster with activated GPI-anchored cell adhesion molecules in non-caveolar micropatches in neurons. J Neurobiol 1998, 37:502-523.
81. Iwabuchi K, Handa K, Hakomori S: Separation of 'glycosphingolipid signaling domain' from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J Biol Chem 1998, 273:33766-33773.
82. McNally EM, de Sa Moreira E, Duggan DJ, Bonnemann CG, Lisanti MP, Lidov HGW, Vainzof M, Passos-Bueno MR, Hoffman EP, Zatz M, Kunkel LM: Caveolin-3 in muscular dystrophy. Hum Mol Genet 1998, 7:871-877. See annotation [83•].
83. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA et al.: Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998, 18:365-368. These studies by McNally et al. [82•] and Minetti et al. [83•] show that in total four different mutations in caveolin-3 (three point mutations and a small deletion) cause a rare form of limb-girdle muscular dystrophy. The elucidation of the underlying molecular defects associated with these mutations is a subject of considerable interest.
84. Garver WS, Hsu SC, Erickson RP, Greer WL, Byers DM, Heidenreich RA: Increased expression of caveolin-1 in heterozygous Niemann-Pick type II human fibroblasts. Biochem Biophys Res Commun 1997, 236:189-193.
85. Garver WS, Hossain GS, Winscott MM, Heidenreich RA: The Npc1 mutation causes an altered expression of caveolin-1, annexin II and protein kinases and phosphorylation of caveolin-1 and annexin II in murine livers. Biochim Biophys Acta 1999, 1453:193-206.
86. Lee SJ, Liyanage U, Bickel PE, Xia W, Lansbury PT Jr, Kosik KS: A detergent-insoluble membrane compartment contains A beta in vivo. Nat Med 1998, 4:730-734.
87. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K: Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998, 95:6460-6464.
88. Ikezu T, Trapp BD, Song KS, Schlegel A, Lisanti MP, Okamoto T: Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein. J Biol Chem 1998, 273:10485-10495.
89. Howland DS, Trusko SP, Savage MJ, Reaume AG, Lang DM, Hirsch JD, Maeda N, Siman R, Greenberg BD, Scott RW, Flood DG: Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J Biol Chem 1998, 273:16576-16582.